SCHEMBL1779652

SCHEMBL1779652

CCOC(=O)n1nc(NC(=O)c2ccccc2NC(=O)c2cnoc2C)c2cc(C(=O)NC(C)(C)c3ccccc3)sc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.36
ABL1 P00519 2/20 0.35
BCR P11274 2/20 0.35
MAPT P10636 5/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
AURKA O14965 1/20 0.34
CSF1R P07333 1/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 5/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HTT P42858 2/20 0.33
POLB P06746 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777881 0.91 HSD17B10 (0.35) RXFP1MAPTRAB9ANPC1CSF1R
SCHEMBL1779174 0.89 RAB9A (0.39) RXFP1MAPTRAB9ANPC1CSF1R
SCHEMBL1780828 0.88 AURKA (0.45) ABL1BCRAURKACSF1R
SCHEMBL1780244 0.88 HSD17B10 (0.38) RXFP1MAPTRAB9ANPC1CSF1R
SCHEMBL1778509 0.87 RXFP1 (0.41) RXFP1MAPTRAB9ANPC1KDM4E
SCHEMBL1778679 0.86 MAPT (0.37) RXFP1ABL1BCRMAPTAURKA
SCHEMBL1779428 0.85 ABL1 (0.40) RXFP1ABL1BCRMAPTAURKA
SCHEMBL1433343 0.85 ABL1 (0.39) RXFP1ABL1BCRMAPTAURKA
SCHEMBL1781304 0.85 KDR (0.37) RXFP1ABL1BCRMAPTRAB9A
SCHEMBL1433182 0.84 RXFP1 (0.38) RXFP1ABL1BCRMAPTAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904503-B1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-11-06 EP disclosed
US-7943654-B2 1H-thieno[2,3-c]pyrazole compounds useful as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-17 US disclosed
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors CCNH, PDK1, MAP3K5 RXFP1 3180/4885ABL1 397/4885BCR 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.